MyFinsight
Home
Blog
About
Proceeds from sale of
marketable securities
$33,144K
Maturities of marketable
securities
$21,515K
Net cash provided by
investing activities
$50,801K
Effect of exchange rate
changes on cash and cash...
$88K
Canceled cashflow
$3,858K
Net (decrease)
increase in cash, cash...
$2,906K
Canceled cashflow
$47,983K
Purchases of fixed assets
$3,858K
Proceeds from exercise of
stock options
$2K
Equity-based compensation
$8,624K
Depreciation and
amortization
$7,676K
Adjustment for credit
losses
$3,667K
Other current and
long-term assets
-$2,280K
Impairment of intangible
assets
$2,172K
Trade accounts
receivable
-$729K
Noncash lease expense
$516K
Contract liabilities
$396K
Loss (gain) on
disposal of fixed asset
-$19K
Net cash used in
financing activities
-$24,225K
Net cash used in
operating activities
-$23,758K
Canceled cashflow
$2K
Canceled cashflow
$26,079K
Repurchase of common stock
$23,805K
Common stock
withholding for employee tax...
$334K
Principal paid for finance
lease
$88K
Net loss from
consolidated operations
-$29,719K
Accrued liabilities and
other liabilities
-$11,896K
Accounts payable
-$3,415K
Customer deposits
-$1,818K
Income tax
-$1,404K
Amortization of premium of
marketable securities
$743K
Operating lease
liabilities
-$505K
Unrecognized tax benefits
$110K
Net (gain) loss on
marketable securities
$90K
Deferred taxes
-$90K
Other
$47K
Back
Back
Cash Flow
Fulgent Genetics, Inc. (FLGT)
Fulgent Genetics, Inc. (FLGT)
source: myfinsight.com